Try our beta test site
4346 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Download search resultsDownload the search results for:
"Sexually Transmitted Diseases, Viral" (4346 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
2 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
3 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
4 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
5 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
6 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
7 Unknown  Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
8 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
9 Completed
Has Results
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
Condition: Condylomata Acuminata
Intervention:
10 Unknown  Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
11 Terminated Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
Condition: Head and Neck Cancer
Interventions: Biological: DNA Vaccine;   Drug: Cyclophosphamide
12 Active, not recruiting Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
Condition: Genital Herpes Simplex Type 2
Intervention: Biological: Observational
13 Completed Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection
Conditions: HIV Infections;   Chikungunya Virus Infection
Intervention: Other: Biological sample collection
14 Completed Safety and Efficacy Study of Topical Rapirnase to Treat Genital Warts (HPV)
Conditions: Condylomata Acuminata;   Papillomavirus Infections;   Sexually Transmitted Diseases
Interventions: Drug: Ranpirnase;   Drug: Vehicle
15 Active, not recruiting Evaluating New Formulation of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2;   Biological: GEN-003;   Drug: Placebo
16 Completed Efficacy and Tolerability of Topical LFX453 for External Genital Warts
Condition: External Genital Warts
Interventions: Drug: LFX453;   Drug: Aldara®
17 Active, not recruiting Topical NVN1000 for the Treatment of External Genital and Perianal Warts
Conditions: Genital Warts;   Perianal Warts
Interventions: Drug: NVN1000;   Other: Vehicle Gel
18 Completed Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2 Adjuvant;   Biological: GEN-003 Vaccine
19 Completed The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
Conditions: Human Papillomavirus Infection;   Genital Warts
Intervention:
20 Completed Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment
Condition: External Genital Warts
Interventions: Drug: Sinecatechins 15% Ointment;   Drug: Cryotherapy alone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.